Diabetes Mellitus, Non-Insulin-Dependent Clinical Trial
Official title:
Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative to Improve Diabetes Care, Its Health Outcomes and Economic Costs
The study tests whether implementing professional evidence-based guidelines and best practices for diabetes care -through participation of multidisciplinary teams in a Breakthrough collaborative- results in an improvement of diabetes care, its health outcomes and economic costs. Determinants of success are studied. Data on diabetes will also be used to better understand Breakthrough as an implementation or improvement method.
Diabetes mellitus as a chronic disease is a major and growing health care problem. Studies
on the prevention of severe complications provide evidence for the necessity of tight
control. Different interventions and models to achieve strict control and reduce diabetes
related risks of complications are available. These are, however, not implemented in daily
practice. Our study focuses on this implementation problem: it tests whether implementing
professional evidence-based guidelines and best practices -through participation of
multidisciplinary teams in the Breakthrough collaborative- results in an improvement of
diabetes care, its health outcomes and economic costs.
Data on diabetes will also be used to explore and better understand the Breakthrough model
as an implementation method. Only uncontrolled observational studies have, so far, described
the outcomes of Breakthrough collaboratives. They also describe significant differences
between teams in specific improvements made in patient care and organisational performance,
resulting in different implementation and medical costs. There is hardly any information
regarding these costs and the cost-effectiveness of collaboratives, and little knowledge
about how they could be made more effective. Insight is also needed into the factors that
influence the success of individual teams. There are no data regarding the sustainability of
improvements.
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02801448 -
Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
|
Phase 2 | |
| Withdrawn |
NCT01377961 -
Effect of Lycopene and Isoflavones on Glucose Metabolism
|
N/A | |
| Completed |
NCT00754130 -
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
|
Phase 1 | |
| Completed |
NCT00006305 -
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00004983 -
Education and Group Support for Diabetic Hispanics
|
N/A | |
| Completed |
NCT00010751 -
Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors
|
Phase 2 | |
| Completed |
NCT02299388 -
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
|
Phase 4 | |
| Completed |
NCT00550329 -
Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
|
Phase 1 | |
| Completed |
NCT00172536 -
Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft
|
N/A | |
| Completed |
NCT00071422 -
Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
|
Phase 2 | |
| Completed |
NCT00029848 -
Obese Patients With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT01608724 -
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT01694758 -
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
|
N/A | |
| Completed |
NCT00979368 -
Safety Study of BMS-816336 in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT00791661 -
MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
|
Phase 1 | |
| Active, not recruiting |
NCT02088658 -
Technology Intensified Diabetes Education Study in African Americans
|
N/A | |
| Completed |
NCT01105429 -
Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
|
Phase 1 | |
| Completed |
NCT00701090 -
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
|
Phase 3 | |
| Completed |
NCT00952991 -
The Effects of LAF237 on Gastric Function in Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00035984 -
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
|
Phase 3 |